Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Ley

Showing results (111-120 of 158) with videos related to

Pageof 16
Sort By:
Blood|December 28, 2007
Identification of somatic JAK1 mutations in patients with acute myeloid leukemiaZhifu Xiang, Yu Zhao, Vesselin Mitaksov, et al.
Cell|February 21, 2017
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML ProgressionDavid H Spencer, David A Russler-Germain, Shamika Ketkar, et al.
Nature Communications|July 28, 2021
Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth SyndromeAmanda M Smith, Taylor A LaValle, Marwan Shinawi, et al.
Plos One|November 14, 2014
Clonal architectures and driver mutations in metastatic melanomasLi Ding, Minjung Kim, Krishna L Kanchi, et al.
Cell Stem Cell|May 1, 2012
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cellsMargaret A Young, David E Larson, Chiao-Wang Sun, et al.
Plos Genetics|July 11, 2014
Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencingAndrew E O Hughes, Vincent Magrini, Ryan Demeter, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2003
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomesTimothy J Ley, Patrick J Minx, Matthew J Walter, et al.
Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
JAMA|April 21, 2011
Use of whole-genome sequencing to diagnose a cryptic fusion oncogeneJohn S Welch, Peter Westervelt, Li Ding, et al.
Blood|January 14, 2017
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapyEric J Duncavage, Geoffrey L Uy, Allegra A Petti, et al.
Pageof 16

Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
Blood|December 28, 2007
Identification of somatic JAK1 mutations in patients with acute myeloid leukemiaZhifu Xiang, Yu Zhao, Vesselin Mitaksov, et al.
Cell|February 21, 2017
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML ProgressionDavid H Spencer, David A Russler-Germain, Shamika Ketkar, et al.
Nature Communications|July 28, 2021
Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth SyndromeAmanda M Smith, Taylor A LaValle, Marwan Shinawi, et al.
Plos One|November 14, 2014
Clonal architectures and driver mutations in metastatic melanomasLi Ding, Minjung Kim, Krishna L Kanchi, et al.
Cell Stem Cell|May 1, 2012
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cellsMargaret A Young, David E Larson, Chiao-Wang Sun, et al.
Plos Genetics|July 11, 2014
Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencingAndrew E O Hughes, Vincent Magrini, Ryan Demeter, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2003
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomesTimothy J Ley, Patrick J Minx, Matthew J Walter, et al.
Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
JAMA|April 21, 2011
Use of whole-genome sequencing to diagnose a cryptic fusion oncogeneJohn S Welch, Peter Westervelt, Li Ding, et al.
Blood|January 14, 2017
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapyEric J Duncavage, Geoffrey L Uy, Allegra A Petti, et al.
Pageof 16